Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Pharmacogenetics of angiotensin system in non diabetic nephropathy].

Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia - 1 Jan 2005

Coto E, Marín R, Alvarez V, Praga M, Fernández Andrade C, Arias M, Poveda R, Vallés M, Galcerán J M, Luño J, Rivera F, Campistol J M

Abstract excerpt

BACKGROUND: Genetic variability could contribute to the response to pharmacological treatment in patients with nephropathy. In albuminuric diabetic patients the renoprotective effect of angiotensin I-converting enzyme (ACE) inhibition should be lower among homozygotes for the deletion allele (DD)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angiotensin II Type 1 Receptor Blockers
Share to Antihypertensive Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Calcium Channel Blockers

Share to Data Interpretation, Statistical

Share to Glomerulonephritis

Share to Kidney Diseases

Share to Losartan

Share to Proteinuria

Source

Identifiers

PMID: 16231503

Genes

ACE
AGT
AGTR1

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-16231503-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Pharmacogenetics of angiotensin system in non diabetic nephropathy].PMID 16231503Read ↗

[Association of the renin-angiotensin system gene polymorphism with nephropathy in type II diabetes].Semantic proximity Read ↗

[Individual renal hemodynamic response to chronic angiotensin II receptor blockade and the influence on the renin-angiotensin system gene polymorphisms].Semantic proximity Read ↗

The influence of renin-angiotensin system genotypes on the antiproteinuric response to high doses of olmesartan in non-diabetic proteinuric nephropathies.Semantic proximity Read ↗

ACE insertion/deletion polymorphism and diabetic nephropathy: clinical implications of genetic information.Semantic proximity Read ↗

[Angiotensin-converting enyme insertion/deletion polymorphism and blood pressure regulation in type 2 diabetic patients].Semantic proximity Read ↗

Genetic variants of ACE (Insertion/Deletion) and AGT (M268T) genes in patients with diabetes and nephropathy.Semantic proximity Read ↗

Antiproteinuric effect of losartan in non-diabetic renal disease is not dependent on ACE insertion/deletion polymorphism.Semantic proximity Read ↗

Genetic polymorphisms of the renin-angiotensin-aldosterone system in end-stage renal disease.Semantic proximity Read ↗

Angiotensin converting enzyme insertion/deletion polymorphism and renoprotection in diabetic and nondiabetic nephropathies.Semantic proximity Read ↗

Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients?Semantic proximity Read ↗

AT2R -1332 G:A polymorphism and diabetic nephropathy in type 2 diabetes mellitus patients.Semantic proximity Read ↗

The effect of polymorphisms in the renin-angiotensin-aldosterone system on diabetic nephropathy risk.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.